OncoSec Medical Balance Sheet Health
Financial Health criteria checks 0/6
OncoSec Medical has a total shareholder equity of $-5.5M and total debt of $7.3M, which brings its debt-to-equity ratio to -132.9%. Its total assets and total liabilities are $8.9M and $14.4M respectively.
Key information
-132.9%
Debt to equity ratio
US$7.29m
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.68m |
| Equity | -US$5.49m |
| Total liabilities | US$14.36m |
| Total assets | US$8.87m |
Recent financial health updates
Recent updates
OncoSec to cut workforce by 45% as part of corporate restructuring
Oct 04What Type Of Shareholders Make Up OncoSec Medical Incorporated's (NASDAQ:ONCS) Share Registry?
Jan 28
Dosing underway in OncoSec's Tavo combo trial in skin cancer
Jan 08OncoSec: Undervalued And Continuing To Make Progress
Nov 18OncoSec drops 11% despite positive data from TAVO + Merck's Keytruda in metastatic melanoma
Nov 09Financial Position Analysis
Short Term Liabilities: ONCS.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ONCS.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ONCS.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: ONCS.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ONCS.Q has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ONCS.Q has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.8% each year